PARTNER 3 Trial - Aortic Valve-in-Valve
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 125 participants.
Also called NCT03003299
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 125 participants
- Sponsor
- Registry
-
NCT03003299
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Canada
- Registry status
- Recruiting
Technical summary
Registry record NCT03003299. Allocation not applicable; no masking; primary purpose treatment. Start 2017-01-05 (actual); primary completion 2033-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PARTNER 3 Trial - Aortic Valve-in-Valve
- Condition
- Aortic Stenosis
- Condition
- Aortic Stenosis, Severe
- Intervention (Device)
- Edwards SAPIEN 3/SAPIEN 3 Ultra THV
- Lead sponsor
- Edwards Lifesciences
Record details
- Record id
cardio:ct-nct03003299- Content hash
6f11bfcf9b6eb45e9f8a81f4c541db761f237217a4e9df57388e18c96e9fd7b2